Zhejiang Shenghua Biok Biology Co Ltd (600226) — Cash Flow-to-Debt Ratio
Zhejiang Shenghua Biok Biology Co Ltd (600226) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥77.05 Million could theoretically repay 0% of its total liabilities (CN¥1.24 Billion) in one year. See financial agility of Zhejiang Shenghua Biok Biology Co Ltd to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Shenghua Biok Biology Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Zhejiang Shenghua Biok Biology Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang Shenghua Biok Biology Co Ltd.
Annual Cash Flow-to-Debt Ratio for Zhejiang Shenghua Biok Biology Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Zhejiang Shenghua Biok Biology Co Ltd. Check how high is Zhejiang Shenghua Biok Biology Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.03x | CN¥-31.31 Million | CN¥1.08 Billion | ▲ +68.8% |
| 2023 | -0.09x | CN¥-76.70 Million | CN¥826.05 Million | ▼ -184.8% |
| 2022 | 0.11x | CN¥25.22 Million | CN¥230.38 Million | ▼ -70.0% |
| 2021 | 0.36x | CN¥105.27 Million | CN¥288.64 Million | ▲ +230.6% |
| 2020 | 0.11x | CN¥46.54 Million | CN¥421.83 Million | ▲ +187.3% |
| 2019 | -0.13x | CN¥-78.22 Million | CN¥619.05 Million | ▲ +47.2% |
| 2018 | -0.24x | CN¥-176.12 Million | CN¥735.73 Million | ▼ -463.6% |
| 2017 | 0.07x | CN¥82.29 Million | CN¥1.25 Billion | ▲ +298.0% |
| 2016 | -0.03x | CN¥-55.29 Million | CN¥1.66 Billion | ▼ -139.2% |
| 2015 | 0.08x | CN¥69.19 Million | CN¥816.58 Million | ▲ +206.7% |
| 2014 | 0.03x | CN¥24.42 Million | CN¥884.11 Million | ▼ -78.8% |
| 2013 | 0.13x | CN¥119.28 Million | CN¥916.13 Million | ▼ -53.2% |
| 2012 | 0.28x | CN¥217.96 Million | CN¥782.86 Million | ▲ +336.2% |
| 2011 | 0.06x | CN¥57.58 Million | CN¥902.06 Million | ▼ -57.4% |
| 2010 | 0.15x | CN¥133.16 Million | CN¥887.98 Million | ▲ +34.8% |
| 2009 | 0.11x | CN¥93.01 Million | CN¥836.27 Million | ▼ -67.0% |
| 2008 | 0.34x | CN¥309.13 Million | CN¥916.34 Million | ▲ +199.2% |
| 2007 | 0.11x | CN¥112.75 Million | CN¥999.98 Million | ▼ -51.5% |
| 2006 | 0.23x | CN¥184.32 Million | CN¥793.49 Million | ▲ +5.3% |
| 2005 | 0.22x | CN¥169.95 Million | CN¥770.72 Million | ▼ -4.9% |
| 2004 | 0.23x | CN¥101.61 Million | CN¥438.24 Million | ▼ -38.7% |
| 2003 | 0.38x | CN¥99.44 Million | CN¥262.80 Million | ▼ -12.5% |
| 2002 | 0.43x | CN¥80.83 Million | CN¥187.01 Million | ▲ +23.1% |
| 2001 | 0.35x | CN¥57.56 Million | CN¥163.93 Million | ▼ -17.1% |
| 2000 | 0.42x | CN¥47.14 Million | CN¥111.31 Million | ▼ -44.8% |
| 1999 | 0.77x | CN¥28.87 Million | CN¥37.60 Million | ▲ +105.1% |
| 1998 | 0.37x | CN¥31.39 Million | CN¥83.86 Million | — |